![OGSIVEO FDA-Approval Featured Image](https://dtrf.org/wp-content/uploads/2023/11/breaking-news-niro-FDA-approval-featured-image-2-720x450.png)
Featured News
FDA APPROVES OGSIVEO™ (NIROGACESTAT), AS THE FIRST MEDICAL THERAPY FOR THE TREATMENT OF ADULTS WITH PROGRESSING DESMOID TUMORS.
Filter by:
![](https://dtrf.org/wp-content/uploads/2023/09/post-fallback.png)
September 13, 2022
*Big News*: Exciting Results Announced For Two Promising Desmoid Tumor Clinical Trials At ESMO Conference In France
![](https://dtrf.org/wp-content/uploads/2023/09/UPDATED_CTOS-Sarcoma-of-the-year_TW_Newsroom-720x450.png)
July 21, 2022
CTOS Names “Desmoid Fibromatosis” The 2022 “Sarcoma Of The Year” For Fall Conference
Read More about CTOS Names “Desmoid Fibromatosis” The 2022 “Sarcoma Of The Year” For Fall Conference
![](https://dtrf.org/wp-content/uploads/2023/09/IG-Registration-is-Open_2022-Weekend_SQ_Newsroom-720x450.png)
June 6, 2022
Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
Read More about Registration Is Open For The 2022 Virtual DTRF “Together We Will” Weekend!
![](https://dtrf.org/wp-content/uploads/2023/09/post-fallback.png)
May 25, 2022
Breaking News: Springworks Therapeutics Announces Topline Results From Phase 3 DeFi Trial
![](https://dtrf.org/wp-content/uploads/2023/09/Radiology-working-group-screenshot_newsletter_Newsroom-720x450.jpeg)
January 28, 2022
DTRF Launches Radiomics Working Group To Improve Tumor Measurement
Read More about DTRF Launches Radiomics Working Group To Improve Tumor Measurement
![](https://dtrf.org/wp-content/uploads/2023/09/Marlene-and-team_RFA_Newsroom-720x450.jpg)
January 24, 2022